ADVANCED SOLID TUMOUR
Clinical trials for ADVANCED SOLID TUMOUR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOUR trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOUR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests a new drug called LBL-024 combined with other medicines in about 110 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to see if the combination can shrink tumors or stop them from growing. Participants will receiv…
Matched conditions: ADVANCED SOLID TUMOUR
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated May 17, 2026 03:28 UTC
-
New drug combo aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis study tests a new drug called LBL-024 combined with other medicines in 140 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to see if the combination can shrink tumors or stop them from growing. Participants will receive the …
Matched conditions: ADVANCED SOLID TUMOUR
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug duo aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis study tests a new drug called LBL-024 combined with other medicines in 110 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to see if the combination can shrink tumors (objective response rate). Participants must be 18 or old…
Matched conditions: ADVANCED SOLID TUMOUR
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New drug cocktail aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called LBL-024 combined with other medicines in 230 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to see if the combination can shrink tumors (objective response rate). Participants will receive the …
Matched conditions: ADVANCED SOLID TUMOUR
Phase: PHASE2 • Sponsor: Nanjing Leads Biolabs Co.,Ltd • Aim: Disease control
Last updated May 06, 2026 16:03 UTC